{"id":9833,"date":"2020-06-09T10:36:28","date_gmt":"2020-06-09T14:36:28","guid":{"rendered":"http:\/\/staging.ibtnetwork.org\/conference\/virtual2020\/video-session-1\/"},"modified":"2020-07-20T17:56:42","modified_gmt":"2020-07-20T21:56:42","slug":"video-session-1","status":"publish","type":"page","link":"https:\/\/ibtnetwork.org\/fr\/conference\/virtual2020\/video-session-1\/","title":{"rendered":"S\u00e9ance 1 IBTN 2020 : Behavioural Solutions for Global Challenges \u2013 Health and Climate Change"},"content":{"rendered":"<p><strong>CONTENUS :<\/strong><\/p>\n<p>Veuillez noter que le congr\u00e8s s\u2019est d\u00e9roul\u00e9 enti\u00e8rement en anglais. Les contenus offerts sont donc uniquement en anglais.<\/p>\n<div class=\"supplemental-block\">\n<p><a href=\"#full\">Visualiser la s\u00e9ance en entier<\/a> (1 h 36 minutes)<\/p>\n<p><a href=\"#Q&amp;A\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9725\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/07\/blog-icon-QandA.gif?resize=25%2C25&#038;ssl=1\" alt=\"\" width=\"25\" height=\"25\" \/> <\/a><a href=\"#Q&amp;A\">Consulter la s\u00e9ance de questions-r\u00e9ponses<\/a><\/p>\n<p><strong>Introduction<\/strong><\/p>\n<ul>\n<li>Men\u00e9e par <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#simon\">Simon Bacon, PhD<\/a>, coresponsable de l&#8217;IBTN<\/li>\n<\/ul>\n<p><strong>Behavioural Medicine for Global Health : Challenges and Opportunities (3:25)<br \/>\n<\/strong><\/p>\n<ul>\n<li>Pr\u00e9sent\u00e9e par <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#bill\">William Riley, PhD<\/a><\/li>\n<li><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9484\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/06\/vidview.png?resize=15%2C14&#038;ssl=1\" alt=\"\" width=\"15\" height=\"14\" \/> <a href=\"https:\/\/ibtnetwork.org\/fr\/conference\/virtual2020\/video-session-1\/video-session-1a\/\">Visualiser uniquement cette pr\u00e9sentation <\/a><\/li>\n<\/ul>\n<p><strong>The role of behavioural medicine in combating climate change (24:20)<br \/>\n<\/strong><\/p>\n<ul>\n<li>Pr\u00e9sent\u00e9e par <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#diefenbach\">Michael Diefenbach, PhD<\/a><\/li>\n<li><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9484\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/06\/vidview.png?resize=15%2C14&#038;ssl=1\" alt=\"\" width=\"15\" height=\"14\" \/> <a href=\"https:\/\/ibtnetwork.org\/fr\/conference\/virtual2020\/video-session-1\/video-session-1b\/\">Visualiser uniquement cette pr\u00e9sentation<\/a><\/li>\n<\/ul>\n<p><strong>The Behavioral Medicine Research Council : Promoting international collaborations in behavioural medicine (44:23) <\/strong><\/p>\n<ul>\n<li>Present\u00e9e par <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#johnr\">John Ruiz, PhD<\/a><\/li>\n<li><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9484\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/06\/vidview.png?resize=15%2C14&#038;ssl=1\" alt=\"\" width=\"15\" height=\"14\" \/> <a href=\"https:\/\/ibtnetwork.org\/fr\/conference\/virtual2020\/video-session-1\/video-session-1c\/\">Visualiser uniquement cette pr\u00e9sentation<\/a><\/li>\n<\/ul>\n<p><strong>Discussion (1:06:00)<br \/>\n<\/strong><\/p>\n<ul>\n<li>Mod\u00e9ratrices :\u00a0 <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#molly\">Molly Byrne, PhD<\/a> et <a href=\"https:\/\/ibtnetwork.org\/fr\/plenary-speakers-2020\/#susanc\">Susan Czajkowski, PhD<\/a><\/li>\n<li><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-9484\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/06\/vidview.png?resize=15%2C14&#038;ssl=1\" alt=\"\" width=\"15\" height=\"14\" \/> <a href=\"https:\/\/ibtnetwork.org\/fr\/conference\/virtual2020\/video-session-1\/video-session-1d\/\">Visualiser uniquement cette partie<\/a><\/li>\n<\/ul>\n<\/div>\n<p id=\"full\"><iframe loading=\"lazy\" title=\"Behavioural Solutions for Global Challenges \u2013 Health and Climate Change\" width=\"1241\" height=\"698\" src=\"https:\/\/www.youtube.com\/embed\/m2RYOcWLX6c?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe><\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" id=\"Q&amp;A\" class=\"alignnone wp-image-9725\" src=\"https:\/\/i0.wp.com\/ibtnetwork.org\/wp-content\/uploads\/2020\/07\/blog-icon-QandA.gif?resize=75%2C75&#038;ssl=1\" alt=\"\" width=\"75\" height=\"75\" \/><\/p>\n<p class=\"emphasis-block\">Nos conf\u00e9renciers ont eu la gentillesse de r\u00e9pondre \u00e0 des questions du public qui avaient \u00e9t\u00e9 laiss\u00e9es sans r\u00e9ponses pendant la p\u00e9riode de discussion.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li><strong>Does the panel think that the \u201cslowness\u201d of behavioural research is due to the nature of our science, or is it a more culturally ingrained issue? For example, we tend to get sticky about the fine grain details of funding applications and lose sight of the bigger picture issues. <\/strong><\/li>\n<\/ol>\n<blockquote><p>Some of the slowness is the nature of behavioral research -e.g., mostly human subjects research, interventions that last weeks, etc. \u2013 but some is more related to our scientific culture \u2013 e.g., why does it take so long for the NIH to review and approve funding for grants?<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"2\">\n<li><strong>To what extent do you think the COVID-19 pandemic will prompt funding agencies to &#8216;streamline&#8217; their review processes? Does the NIH have any specific plans to move to a new, more rapid\/streamlined process and how can you help encourage international agencies to do the same (e.g. CIHR in Canada).<\/strong><\/li>\n<\/ol>\n<blockquote><p>The NIH also streamlined processes during ARRA (2008 economic stimulus) but mostly returned to standard procedures afterwards.\u00a0 We\u2019re hopeful that we can maintain some of the streamlined procedures following the pandemic.<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"3\">\n<li><strong>Technically speaking, are there ways by which we can remove the effects of subjectivity on self-report measures (mainly physical activity &amp; dietary indices)? As they are basically originating from a self-report and recall nature&#8230;<\/strong><\/li>\n<\/ol>\n<blockquote><p>Reducing the retrospective nature (e.g., using EMA) at least reduces the recall biases. \u00a0And more modern psychometric approaches (e.g., IRT) can improve precision and accuracy.\u00a0 Within clinical trials that are not blinded, useful to test for the perception of equipoise among participants and to ask for self-report at times when the intervention assigned is not so salient \u2013 e.g., during the same visit in which they received the intervention.<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"4\">\n<li><strong>Has any research been done to ask funded researchers why they have not published in a timely fashion at all? Are there any common factors?<\/strong><\/li>\n<\/ol>\n<blockquote><p>Very little.\u00a0 We know some risk factors that tend to result in longer lags to publication \u2013 e.g., human research, clinical trials, longitudinal studies, but those explain only some of the variance.<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"5\">\n<li>Should we be endeavouring to do more collaborative, large-scale research including harmonizing data collection methods and measures? How do you overcome challenges related to cross-cultural applicability (and non-applicability) for many measures that were developed in the West (often the US) and which may lack face validity in other contexts?<\/li>\n<\/ol>\n<blockquote><p>Yes \u2013 we conduct too many underpowered studies that inadequately represent the breadth of potential patients.\u00a0 Important to harmonize, but excellent point about different cultural contexts.\u00a0 Developing IRT item banks and co-calibrating items across groups and cultures is one way to address these measurement differences.<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"6\">\n<li>Where much funding comes for applications of behavioural medicine, how do we ensure that the fundamental scientific questions about human behaviour are asked and answered?<\/li>\n<\/ol>\n<blockquote><p>NIH funds considerable basic behavioral and social sciences research.\u00a0 Actually, about half of NIH funding for BSSR is basic research.\u00a0 OBSSR is focused primarily on the translation of basic to applied and back.<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<ol start=\"7\">\n<li>Do you have any thoughts to share on accounting for the differences between health systems from country to country within international behavioural trials?<\/li>\n<\/ol>\n<blockquote><p>Clearly an important contextual factor to consider when it is reasonable to assume that the health systems impact the behavior or outcome of interest.\u00a0 However, it would take a quite large trans-country design to have enough of the common types of health systems to assess this effect with any degree of certainty.\u00a0 It may be useful to at least consider assessing the mechanisms by which these different health systems have their effect (e.g., access to specific care).<\/p>\n<footer>\u2013 <cite>William Riley &#8211; conf\u00e9rencier<\/cite><\/footer>\n<\/blockquote>\n<div class=\"footnote\">\n<p>VEUILLEZ NOTER : Bien que de nombreuses questions aient \u00e9t\u00e9 soumises par les participants au congr\u00e8s, seules les questions pour lesquelles nous avons obtenu des r\u00e9ponses sont partag\u00e9es ici.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>There is no summary available for this post.<\/p>\n","protected":false},"author":179,"featured_media":0,"parent":8784,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/full-width-page.php","meta":{"footnotes":""},"wf_page_folders":[],"class_list":["post-9833","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/pages\/9833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/users\/179"}],"replies":[{"embeddable":true,"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/comments?post=9833"}],"version-history":[{"count":0,"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/pages\/9833\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/pages\/8784"}],"wp:attachment":[{"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/media?parent=9833"}],"wp:term":[{"taxonomy":"wf_page_folders","embeddable":true,"href":"https:\/\/ibtnetwork.org\/fr\/wp-json\/wp\/v2\/wf_page_folders?post=9833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}